Kanada - angleščina - Health Canada

nu-pharm inc - sulindac - tablet - 150mg - sulindac 150mg - other nonsteroidal antiimflammatory agents

Kanada - angleščina - Health Canada

nu-pharm inc - sulindac - tablet - 200mg - sulindac 200mg - other nonsteroidal antiimflammatory agents

Kanada - angleščina - Health Canada

pentapharm ltd. - sulindac - tablet - 150mg - sulindac 150mg - other nonsteroidal antiimflammatory agents

Kanada - angleščina - Health Canada

pentapharm ltd. - sulindac - tablet - 200mg - sulindac 200mg - other nonsteroidal antiimflammatory agents

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

apotex nz ltd - sulindac 200mg;   - tablet - 200 mg - active: sulindac 200mg   excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

essential generics ltd - sulindac - oral tablet - 100mg

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

essential generics ltd - sulindac - oral tablet - 200mg

Združene države Amerike - angleščina - NLM (National Library of Medicine)

major pharmaceuticals - sulindac (unii: 184sns8vuh) (sulindac - unii:184sns8vuh) - carefully consider the potential benefits and risks of sulindac tablets and other treatment options before deciding to use sulindac tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). sulindac tablets are indicated for acute or long-term use in the relief of signs and symptoms of the following: sulindac tablets are contraindicated in patients with known hypersensitivity to sulindac or the excipients (see description ). sulindac tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic/anaphylactoid reactions to nsaids have been reported in such patients (see warnings – anaphylactic/anaphylactoid reactions , and precautions – preexisting asthma ).

Namibija - angleščina - Namibia Medicines Regulatory Council

adcock ingram limited - sulindac - tablets - each tablet contains sulindac 200 mg

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - sulindac - oral tablet - 100mg